Please use this identifier to cite or link to this item:
Title: Patient centricity : the patient ambassador program at Grunenthal
Authors: Grunenthal Group
Keywords: Patient care
Pharmaceutical industry -- Germany
Issue Date: 2014
Publisher: Medical Portals Ltd.
Citation: Grünenthal Group. (2014). Patient centricity : the patient ambassador program at Grunenthal. The Synapse, 13(2), 19
Abstract: The Grünenthal Group is an independent, family-owned, international research-based pharmaceutical company headquartered in Aachen, Germany. Building on its unique position in pain treatment, its objective is to become the most patient-centric company in the field of pain and thus to be a leader in therapy innovation. Grünenthal is one of the last remaining five research-oriented pharmaceutical companies with headquarters in Germany which sustainably invests in research and development
Appears in Collections:The Synapse, Volume 13, Issue 2
The Synapse, Volume 13, Issue 2

Files in This Item:
File Description SizeFormat 
Patient centricity.pdf367.9 kBAdobe PDFView/Open

Items in OAR@UM are protected by copyright, with all rights reserved, unless otherwise indicated.